DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
OMS405
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
OMS405
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C11H15ClNO4PS
Molecular Weight:
323.74
AlogP:
4.38
PSA:
61.6
HBD:
0.0
HBA:
#RotB:
6.0
Source:
EPETIRIMOD ESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPETIRIMOD ESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H92K6N217F
Molecule Type:
Small molecule
Molecular Formula:
C15H23N5O4S
Molecular Weight:
369.45
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BXT-51072
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BXT-51072
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPB-348
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPB-348
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBATOCLAX
2
Small molecule
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma; Leukemia, Myeloid, Acute
Unknown
OBATOCLAX
×
Maximum Phase:
2
First Approval:
None
UNII:
QN4128B52A
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O
Molecular Weight:
317.39
AlogP:
4.49
PSA:
53.17
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BFH-772
2
Small molecule
Investigational
Unknown
Unknown
Rosacea
Vascular endothelial growth factor receptor 2 inhibitor
BFH-772
×
Maximum Phase:
2
First Approval:
None
UNII:
T1IV236CVP
Molecule Type:
Small molecule
Molecular Formula:
C23H16F3N3O3
Molecular Weight:
439.39
AlogP:
5.19
PSA:
84.34
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FAPI GA-68
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Psoriatic; Fibrosis; Myositis; Neoplasms
Unknown
FAPI GA-68
×
Maximum Phase:
2
First Approval:
None
UNII:
TUK9QB44B0
Molecule Type:
Small molecule
Molecular Formula:
C40H53GaN10O10
Molecular Weight:
903.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BERUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
BERUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
6QPN83HK2M
Molecule Type:
Small molecule
Molecular Formula:
C34H35NO11
Molecular Weight:
633.65
AlogP:
2.23
PSA:
195.07
HBD:
5.0
HBA:
#RotB:
8.0
Source:
ATIPRIMOD
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Carcinoma, Neuroendocrine
Unknown
ATIPRIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
MG7D3QD743
Molecule Type:
Small molecule
Molecular Formula:
C22H44N2
Molecular Weight:
336.61
AlogP:
5.57
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
10.0
Source:
BVT.115959
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Adenosine A2a receptor agonist
BVT.115959
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O5
Molecular Weight:
297.27
AlogP:
-1.97
PSA:
148.77
HBD:
4.0
HBA:
#RotB:
3.0
Source:
TOSEDOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Pancreatic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Aminopeptidase inhibitor
TOSEDOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
KZK563J2UW
Molecule Type:
Small molecule
Molecular Formula:
C21H30N2O6
Molecular Weight:
406.48
AlogP:
1.86
PSA:
124.96
HBD:
4.0
HBA:
#RotB:
9.0
Source:
PF-00446687
2
Small molecule
Investigational
Unknown
Unknown
Erectile Dysfunction; Sexual Dysfunction, Physiological
Melanocortin receptor 4 agonist
PF-00446687
×
Maximum Phase:
2
First Approval:
None
UNII:
63P236Z73I
Molecule Type:
Small molecule
Molecular Formula:
C28H36F2N2O2
Molecular Weight:
470.6
AlogP:
4.78
PSA:
43.78
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ITRIGLUMIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
ITRIGLUMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
879A12466H
Molecule Type:
Small molecule
Molecular Formula:
C33H38N2O4
Molecular Weight:
526.68
AlogP:
6.84
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BEDORADRINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BEDORADRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4EAR229231
Molecule Type:
Small molecule
Molecular Formula:
C24H32N2O5
Molecular Weight:
428.53
AlogP:
1.57
PSA:
102.26
HBD:
4.0
HBA:
#RotB:
9.0
Source:
SAFOTIBANT
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Bradykinin B1 receptor antagonist
SAFOTIBANT
×
Maximum Phase:
2
First Approval:
None
UNII:
02HU8HWP7U
Molecule Type:
Small molecule
Molecular Formula:
C25H34N4O5S
Molecular Weight:
502.64
AlogP:
1.96
PSA:
100.54
HBD:
1.0
HBA:
#RotB:
11.0
Source:
CI-1040
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Lung Neoplasms; Pancreatic Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
CI-1040
×
Maximum Phase:
2
First Approval:
None
UNII:
R3K9Y00J04
Molecule Type:
Small molecule
Molecular Formula:
C17H14ClF2IN2O2
Molecular Weight:
478.66
AlogP:
5.04
PSA:
50.36
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TESOFENSINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Diabetes Mellitus, Type 2; Obesity; Parkinson Disease; Prader-Willi Syndrome
Monoamine transporter inhibitor
TESOFENSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
BLH9UKX9V1
Molecule Type:
Small molecule
Molecular Formula:
C17H23Cl2NO
Molecular Weight:
328.28
AlogP:
4.6
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
4.0
Source:
OXIRACETAM
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
OXIRACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
P7U817352G
Molecule Type:
Small molecule
Molecular Formula:
C6H10N2O3
Molecular Weight:
158.16
AlogP:
-1.94
PSA:
83.63
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GALLOPAMIL
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Cardiovascular Diseases
Unknown
GALLOPAMIL
×
Maximum Phase:
2
First Approval:
None
UNII:
39WPC8JHR8
Molecule Type:
Small molecule
Molecular Formula:
C28H40N2O5
Molecular Weight:
484.64
AlogP:
5.1
PSA:
73.18
HBD:
0.0
HBA:
#RotB:
14.0
Source:
UPAMOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Severe Acute Respiratory Syndrome
Unknown
UPAMOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
S5M7KW6U17
Molecule Type:
Small molecule
Molecular Formula:
C32H47N5O6S
Molecular Weight:
629.82
AlogP:
4.34
PSA:
154.63
HBD:
3.0
HBA:
#RotB:
11.0
Source:
SIMUFILAM
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Neurogenic Inflammation; Alzheimer Disease
Filamin-A positive modulator
SIMUFILAM
×
Maximum Phase:
2
First Approval:
None
UNII:
6NV440YIO0
Molecule Type:
Small molecule
Molecular Formula:
C15H21N3O
Molecular Weight:
259.35
AlogP:
1.04
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LY2245461
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Estrogen receptor modulator
LY2245461
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-906024
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-906024
×
Maximum Phase:
2
First Approval:
None
UNII:
DRL23N424R
Molecule Type:
Small molecule
Molecular Formula:
C26H26F6N4O3
Molecular Weight:
556.51
AlogP:
4.35
PSA:
104.86
HBD:
2.0
HBA:
#RotB:
9.0
Source:
GENISTEIN
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Cystic Fibrosis; Neoplasms; Rectal Neoplasms; Breast Neoplasms; Coronary Disease; Metabolic Syndrome; Osteoporosis; Pancreatic Neoplasms; Post-Acute COVID-19 Syndrome; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pulmonary Fibrosis; Severe Acute Respiratory Syndrome; Urinary Bladder Neoplasms
Unknown
GENISTEIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DH2M523P0H
Molecule Type:
Small molecule
Molecular Formula:
C15H10O5
Molecular Weight:
270.24
AlogP:
2.58
PSA:
90.9
HBD:
3.0
HBA:
#RotB:
1.0
Source:
MAVELERTINIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
MAVELERTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
YXX2180047
Molecule Type:
Small molecule
Molecular Formula:
C18H22FN9O2
Molecular Weight:
415.43
AlogP:
0.68
PSA:
115.02
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ELUBRIXIN
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Colitis, Ulcerative; Cystic Fibrosis
Interleukin-8 receptor B antagonist
ELUBRIXIN
×
Maximum Phase:
2
First Approval:
None
UNII:
MW2AIJ8USP
Molecule Type:
Small molecule
Molecular Formula:
C17H17Cl2FN4O4S
Molecular Weight:
463.32
AlogP:
3.08
PSA:
110.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
RELCOVAPTAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Oxytocin receptor antagonist
RELCOVAPTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
C1GL8G6G0O
Molecule Type:
Small molecule
Molecular Formula:
C28H27Cl2N3O7S
Molecular Weight:
620.51
AlogP:
3.3
PSA:
139.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CP-778875
2
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders
Peroxisome proliferator-activated receptor alpha agonist
CP-778875
×
Maximum Phase:
2
First Approval:
None
UNII:
2MUX3DX6TR
Molecule Type:
Small molecule
Molecular Formula:
C23H23NO4S2
Molecular Weight:
441.57
AlogP:
5.35
PSA:
83.47
HBD:
2.0
HBA:
#RotB:
8.0
Source:
PF-232798
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
C-C chemokine receptor type 5 inhibitor
PF-232798
×
Maximum Phase:
2
First Approval:
None
UNII:
63P7W7886U
Molecule Type:
Small molecule
Molecular Formula:
C29H40FN5O2
Molecular Weight:
509.67
AlogP:
4.31
PSA:
70.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RIMTUZALCAP
2
Small molecule
Investigational
Unknown
Unknown
Spinocerebellar Ataxias; Essential Tremor
Unknown
RIMTUZALCAP
×
Maximum Phase:
2
First Approval:
None
UNII:
USO2D5J77R
Molecule Type:
Small molecule
Molecular Formula:
C18H24F2N6O
Molecular Weight:
378.43
AlogP:
2.8
PSA:
68.1
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DENAGLIPTIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
DENAGLIPTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DOS9ZOT21L
Molecule Type:
Small molecule
Molecular Formula:
C20H18F3N3O
Molecular Weight:
373.38
AlogP:
2.89
PSA:
70.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LADOSTIGIL
2
Small molecule
Investigational
Unknown
Unknown
Dementia
Unknown
LADOSTIGIL
×
Maximum Phase:
2
First Approval:
None
UNII:
SW3H1USR4Q
Molecule Type:
Small molecule
Molecular Formula:
C16H20N2O2
Molecular Weight:
272.35
AlogP:
2.35
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EDRALBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Autoimmune Diseases; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neoplasms; Kidney Diseases; Neuromyelitis Optica
Tyrosine-protein kinase BTK inhibitor
EDRALBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
SG5I5QTR4E
Molecule Type:
Small molecule
Molecular Formula:
C26H21F2N5O3
Molecular Weight:
489.48
AlogP:
3.84
PSA:
106.24
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BI-811283
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Leukemia, Myeloid, Acute
Serine/threonine-protein kinase Aurora-B inhibitor
BI-811283
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRX0014
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRX0014
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
114
115
116
117
118
119
120
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA